ARCHIVES

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Lasagna Committee Urges Medicare Payment for Experimental Drugs, Care

September 29, 1989

U.S., Canada To Collaborate On Indian Health Services.

May 17, 2002

In Brief: Cancer Act, Accelerated Progress, ACS President Says; Scanners Scapegoats, EMI Chief Claimes

April 7, 1978

National Lung Cancer Partnership Announces Annual Grant Competition

August 9, 2013

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

January 7, 1983

RFA: Native American Women’s Cancer Initiative

July 9, 1993